309 related articles for article (PubMed ID: 26191186)
1. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
Tian X; Xu L; Wang P
Int J Clin Exp Pathol; 2015; 8(5):4933-42. PubMed ID: 26191186
[TBL] [Abstract][Full Text] [Related]
2. MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3.
Dong M; Yang P; Hua F
Med Sci Monit; 2015 Mar; 21():915-20. PubMed ID: 25819812
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
5. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation.
Cui Z; An X; Li J; Liu Q; Liu W
Biomed Pharmacother; 2018 Aug; 104():223-228. PubMed ID: 29775889
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
[TBL] [Abstract][Full Text] [Related]
8. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-141-3p targets DAPK1 and inhibits apoptosis in rat ovarian granulosa cells.
Li D; Xu D; Xu Y; Chen L; Li C; Dai X; Zhang L; Zheng L
Cell Biochem Funct; 2017 Jun; 35(4):197-201. PubMed ID: 28543175
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
12. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
13. Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Bhardwaj P
Indian J Med Res; 2022 Sep; 156(3):516-523. PubMed ID: 36751747
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
15. MiR‑381 regulates cell motility, growth and colony formation through PIK3CA in endometriosis‑associated clear cell and endometrioid ovarian cancer.
Hsu CY; Hsieh TH; Er TK; Chen HS; Tsai CC; Tsai EM
Oncol Rep; 2018 Dec; 40(6):3734-3742. PubMed ID: 30542723
[TBL] [Abstract][Full Text] [Related]
16. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
[TBL] [Abstract][Full Text] [Related]
17. DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis.
Yoo HJ; Byun HJ; Kim BR; Lee KH; Park SY; Rho SB
Cell Signal; 2012 Jul; 24(7):1471-7. PubMed ID: 22465880
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
[TBL] [Abstract][Full Text] [Related]
20. The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.
Banz C; Ungethuem U; Kuban RJ; Diedrich K; Lengyel E; Hornung D
Fertil Steril; 2010 Sep; 94(4):1212-1217. PubMed ID: 19643405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
